Latest Conference

Vikas Gupta, PharmD, BCPS, director of Clinical Strategy at Becton Dickinson, discusses his research on the national prevalence of multidrug-resistant organisms.

Speakers at the Infectious Diseases Society of America annual conference plenary symposium in New Orleans, Louisiana, discuss past successes, current challenges, and future efforts regarding infectious disease.

Zika has been around for a long time, with the first report dating back to 1947. Until 2007, only 14 cases had been reported. Subsequently, there have been three outbreaks, culminating with its arrival in the Americas in the 2015 epidemic in Brazil.

At the Infectious Diseases Society of America Meeting, in New Orleans, Louisiana, Octavio Ramilo, MD, Nationwide Children’s Hospital, Columbus, Ohio, gave a lecture on advancements being made when it comes to host response and pathogenesis of respiratory syncytial virus.

Kenneth Fife, MD, PhD, Professor of Medicine at Indiana University, School of Medicine, discusses whether or not his genital herpes vaccine, GEN-003, can protect against oral herpes.

Pedro Fernando da Costa Vasconcelos, MD, PhD, director of WHO Collaborating Center for Arbovirus and Research, Evandro Chagas Institute, discusses the prognosis of babies with Zika-related complications.

Pedro Fernando da Costa Vasconcelos, MD, PhD, director of WHO Collaborating Center for Arbovirus and Research, Evandro Chagas Institute, discusses whether or not all Zika-infected pregnant women will infect their fetuses.

Pedro Fernando da Costa Vasconcelos, MD, PhD, director of WHO Collaborating Center for Arbovirus and Research, Evandro Chagas Institute, discusses the likelihood that fetuses congenitally infected with the Zika virus will develop related complications, such as microcephaly.

Pedro Fernando da Costa Vasconcelos, MD, PhD, director of WHO Collaborating Center for Arbovirus and Research, Evandro Chagas Institute, discusses the possibility of the Zika virus evolving to cause other complications in the future.

Pedro Fernando da Costa Vasconcelos, MD, PhD, director of WHO Collaborating Center for Arbovirus and Research, Evandro Chagas Institute, explains how Zika has evolved since the 1960s.

Andrew Chasteen from Accelerate Diagnostics, Inc, explains future applications of Morphokinetic Cellular Analysis (MCA).

Kirk Hevener, PharmD, PhD, assistant professor of Biomedical and Pharmaceutical Sciences at Idaho State University, College of Pharmacy, explains his research regarding topoisomerase I and II enzymes.

Kirk Hevener, PharmD, PhD, assistant professor of Biomedical and Pharmaceutical Sciences at Idaho State University, College of Pharmacy, discusses the advantages of narrow spectrum antibiotics.

Kirk Hevener, PharmD, PhD, assistant professor of Biomedical and Pharmaceutical Sciences at Idaho State University, College of Pharmacy, explains how clinicians can identify pathogenic organisms to determine which narrow spectrum antibiotic to use for treatment.

Justin R. Anderson, PhD, associate professor of biology at Radford University, explains the factors that make some people more susceptible to contracting mosquito-borne viruses.

Justin R. Anderson, PhD, associate professor of biology at Radford University, discusses what factors will aid mosquito control specialists in eradicating vector populations.

Justin R. Anderson, PhD, associate professor of biology at Radford University, discusses how endocrine disrupting chemicals interact with larvae to change infected mosquitoes.

Kirk Hevener, PharmD, PhD, assistant professor of Biomedical and Pharmaceutical Sciences at Idaho State University, College of Pharmacy, explains the difference between topoisomerase I and quinolone antibacterials.

Craig Rubens, MD, PhD, co-founder and executive director of GAPPS at Seattle Children’s Hospital, discusses the goals of the Global Alliance to Prevent Prematurity and Stillbirth (GAPPS).

Craig Rubens, MD, PhD, co-founder and executive director of GAPPS at Seattle Children’s Hospital, discusses the need for more research on neonatal infections.

Craig Rubens, MD, PhD, co-founder and executive director of GAPPS at Seattle Children’s Hospital, discusses the importance of understanding the global burden of neonatal death and disease.

Romney Humphries, PhD, D(ABMM), section chief of Clinical Microbiology at the University of California, Los Angeles, discusses how stewardship recommendations can drive change in how physicians manage their patients.

Romney Humphries, PhD, D(ABMM), section chief of Clinical Microbiology at the University of California, Los Angeles, discusses the importance of minimizing the gap between clinical trial data and real world outcomes.

Otto Schwake, PhD, Department of Civil and Environmental Engineering at Virginia Tech, lead researcher from the Flint Water Study team, explains how metals affect the growth of Legionella.

Romney Humphries, PhD, D(ABMM), section chief of Clinical Microbiology at the University of California, Los Angeles, discusses the two approaches used to detect antimicrobial susceptibility: genotypic and phenotypic.

Otto Schwake, PhD, Department of Civil and Environmental Engineering at Virginia Tech, lead researcher from the Flint Water Study team, explains the danger Legionella poses.

Otto Schwake, PhD, Department of Civil and Environmental Engineering at Virginia Tech, lead researcher from the Flint Water Study team, explains how the material of water pipes can have public health implications.

Andrea Endimiani, MD, PhD, professor at the Institute for Infectious Diseases at the University of Bern, Switzerland, discusses how antibiotic stewardship can reduce the risk of antimicrobial-resistant superbugs.

Otto Schwake, PhD, Department of Civil and Environmental Engineering at Virginia Tech, lead researcher from the Flint Water Study team, explains why in Flint, Michigan, Legionella prevalence differed based on building size

Andrea Endimiani, MD, PhD, professor at the Institute for Infectious Diseases at the University of Bern, Switzerland, discusses how scientists can neutralize the mcr-1 gene.